Lower levels of cyclosporine between days 0 and +21 may reduce later relapses without increasing graft‐versus‐host disease in children and adolescents with acute lymphoblastic leukemia who undergo myeloablative <scp>TBI</scp> ‐based allogeneic hematopoietic cell transplantation-Reference-Cited by-同舟云学术

Lower levels of cyclosporine between days 0 and +21 may reduce later relapses without increasing graft‐versus‐host disease in children and adolescents with acute lymphoblastic leukemia who undergo myeloablative TBI ‐based allogeneic hematopoietic cell transplantation

Published:2022-05-29 Issue:2 Volume:109 Page:182-185
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:European J of Haematology

Author:

Arcuri Leonardo Javier¹^ORCID,Lerner Decio¹,Tavares Rita de Cassia Barbosa da Silva¹

Affiliation:

1. Department of Bone Marrow Transplantation Instituto Nacional de Cancer Rio de Janeiro Brazil

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13787

Reference15 articles.

1. Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission;Pidala J;Cochrane Database Syst Rev,2011

2. Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study

3. Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing cyclosporine A dose post allogeneic hematopoietic stem cell transplantation in paediatric cancer patients;Journal of Oncology Pharmacy Practice;2023-08-01